en.wikipedia.org website review
Improve your SEO :: free trial!
en.wikipedia.org is 59% geoptimaliseerd!
SEO Keyword summary for en.wikipedia.org/wiki/siltuximab
Keywords are extracted from the main content of your website and are the primary indicator of the words this page could rank for. By frequenty count we expect your focus keyword to be interleukin
Focus keyword
Short and long tail
Short Tail Keywords interleukin siltuximab il- |
long Tail Keywords (2 words) agonists interleukin monoclonal antibody b c 8 june maint overridden |
long Tail Keywords (3 words) 8 june 2024 journal cs1 maint c d e b c d move to sidebar retrieved 8 june cs1 maint overridden |
en.wikipedia.org On-Page SEO Scan
Descriptive Elements
The <head> element of a en.wikipedia.org/wiki/siltuximab page is used to inform the browser and visitors of the page about the general meta information. The head section of the page is where we place the page title, the definition of the HTML version used, the language of in which the page is written. In the head section we can also include JavaScript and CSS (markup) files for the page.
Page title
Title length
siltuximab wikipedia
Meta description
Meta description legth
Meta description SEO
No meta relevance in the description detected !
Content SEO
Number of Words
Spam detected?
Headings
Heading distribution
Heading normalisation
Heading SEO impact
Emphasis (bold and italic)
Emphasis SEO impact
Images
Number of images
Images dimensions
Image alt descriptions
Images SEO impact
wikipedia free encyclopedia check public domain icon wikimedia foundation powered mediawiki
Mobile SEO en.wikipedia.org/wiki/siltuximab
Mobile rendering
Mobile optimizations
Responsive design detected (mobile css)
No flash detected !
Mobile improvement
Marketing / lead generation for en.wikipedia.org/wiki/siltuximab
Social Media
Facebook shares | Facebook likes | ||
Facebook comments | Tweets | ||
Google +1 |
Conversion form
Search form
Analytics
Online presence
SERP Preview
SERP Title
SERP Link
SERP Description
Domain Level SEO
Domain name
16 characters long
Domain name SEO Impact
Path name
siltuximab found in path !
Structured data
Publisher Markup
Other Structured data
Website configuration
Correct processing of non-existing pages?
Favicon icon found?
Robots.txt found?
Sitemap found?
Navigation and internal links
Navigation
Url seperator
Human readable urls
Number of links
Link SEO Impact
statistics
|
en.m.wikipedia.org |
en.wikipedia.org wikimedia foundation inc
|
w view history
httpsenwikipediaorgwindexphptitlesiltuximaboldid1227859537
page information
printable version
botensilimab
adargileukin alfa
pegaldesleukin
atexakin alfa
edodekin alfa
cintredekin besudotox
interferon 4 ifn4
efineptakin alfa
|
wiki read
monoclonal antibodies
chimeric
mouse
human
target
interleukin6
trade names
legal status
dailymed
l04
only
cas number
drugbank
chemspider
kegg
chembl
formula
molar mass
castlemans disease
fusion
proteins
hiv
hhv8
indicated
cyp450
blymphocytes
plasma cells
vegf
castleman disease
nonhodgkins lymphoma
metastatic
renal cell cancer
prostate cancer
ovarian cancer
response rates
world health organization
food and drug administration
public domain
fajgenbaum dc
pmid
s2cid
immunosuppressive drugs
immunosuppressants
antimetabolites
purine synthesis inhibitors
azathioprine
mycophenolic acid
dihydroorotate dehydrogenase
leflunomide
teriflunomide
antifolate
methotrexate
macrolides
interleukin 2
fkbp
cyclophilin
calcineurin
ciclosporin
pimecrolimus
tacrolimus
voclosporin
abetimus
gusperimus
lenalidomide
pomalidomide
thalidomide
pde4 inhibitor
apremilast
anakinra
mtor
sirolimus
everolimus
ridaforolimus
temsirolimus
umirolimus
zotarolimus
antibodies
complement component 5
eculizumab
tnf inhibitor
adalimumab
afelimomab
certolizumab pegol
golimumab
infliximab
nerelimomab
interleukin
basiliximab
bimekizumab
briakinumab
brodalumab
canakinumab
daclizumab dacliximab
guselkumab
ixekizumab
olokizumab
rilonacept il1 trap
risankizumab
sarilumab
satralizumab
secukinumab
sirukumab
spesolimab
tildrakizumab
tocilizumab
ustekinumab
interleukin 5
mepolizumab
immunoglobulin e
omalizumab
interferon
faralimomab
interleukin 6
elsilimomab
interleukin 12
interleukin 23 sgrf
lebrikizumab
interleukin 17
muromonabcd3
otelixizumab
teplizumab
visilizumab
cd4
clenoliximab
keliximab
zanolimumab
cd11a
efalizumab
cd18
erlizumab
cd20
obinutuzumab
ocrelizumab
pascolizumab
rituximab
ublituximab
cd23
gomiliximab
lumiliximab
cd40
teneliximab
toralizumab
cd62llselectin
aselizumab
cd80
galiximab
cd147basigin
gavilimomab
cd154
ruplizumab
frexalimab
belimumab
bertilimumab
lerdelimumab
metelimumab
integrin
natalizumab
vedolizumab
odulimomab
il2 receptorcd25
inolimomab
tlymphocyte
zolimomab aritox
alemtuzumab
anifrolumab
atorolimumab
cedelizumab
emapalumab
fontolizumab
inebilizumab
maslimomab
morolimumab
ofatumumab
pexelizumab
reslizumab
rovelizumab
siplizumab
talizumab
telimomab aritox
teprotumumab
vapaliximab
vepalimomab
polyclonal
antithymocyte globulin
antilymphocyte globulin
ctla4
abatacept
belatacept
etanercept
aflibercept
alefacept
avacopan
baricitinib
blisibimod
crovalimab
danicopan
deucravacitinib
efgartigimod alfa
hyaluronidase
etrasimod
filgotinib
fingolimod
iptacopan
ozanimod
peficitinib
pegcetacoplan
ponesimod
ravulizumab
ritlecitinib
rozanolixizumab
siponimod
sutimlimab
tofacitinib
upadacitinib
tumor
adecatumumab
amivantamab
ascrinvacumab
atezolizumab
cixutumumab
conatumumab
daratumumab
drozitumab
duligotumab
dusigitumab
enfortumab vedotin
enoticumab
figitumumab
flanvotumab
ganitumab
glembatumumab vedotin
intetumumab
ipilimumab
iratumumab
istiratumab
icrucumab
lexatumumab
lucatumumab
mapatumumab
narnatumab
necitumumab
nesvacumab
nivolumab
olaratumab
panitumumab
patritumab
pembrolizumab
pritumumab
radretumab
ramucirumab
rilotumumab
robatumumab
seribantumab
sugemalimab
tarextumab
tisotumab vedotin
tovetumab
vantictumab
votumumab
zalutumumab
abagovomab
altumomab pentetate
anatumomab mafenatox
arcitumomab
bectumomab
blinatumomab
capromab pendetide
detumomab
edrecolomab
ibritumomab tiuxetan
igovomab
lilotomab
minretumomab
mitumomab
nacolomab tafenatox
moxetumomab pasudotox
naptumomab estafenatox
oregovomab
pemtumomab
racotumomab
satumomab pendetide
solitomab
taplitumomab paptox
nofetumomab merpentan
pintumomab
tenatumomab
tositumomab
amatuximab
bavituximab
brentuximab vedotin
carotuximab
cetuximab
derlotuximab biotin
dinutuximab
ecromeximab
ensituximab
futuximab
girentuximab
indatuximab ravtansine
isatuximab
loncastuximab tesirine
margetuximab
mirvetuximab soravtansine
zolbetuximab
humanized
abituzumab
belantamab mafodotin
bevacizumab
bivatuzumab mertansine
brontictuzumab
cantuzumab mertansine
cantuzumab ravtansine
cirmtuzumab
citatuzumab bogatox
clivatuzumab tetraxetan
cofetuzumab pelidotin
dacetuzumab
demcizumab
dalotuzumab
denintuzumab mafodotin
elotuzumab
emactuzumab
emibetuzumab
enoblituzumab
epcoritamab
etaracizumab
farletuzumab
ficlatuzumab
flotetuzumab
gemtuzumab ozogamicin
glofitamab
imgatuzumab
inotuzumab ozogamicin
labetuzumab
lifastuzumab vedotin
lintuzumab
lorvotuzumab mertansine
lumretuzumab
matuzumab
milatuzumab
naxitamab
nimotuzumab
ocaratuzumab
otlertuzumab
onartuzumab
oportuzumab monatox
parsatuzumab
pertuzumab
pinatuzumab vedotin
polatuzumab vedotin
rosmantuzumab
rovalpituzumab tesirine
sacituzumab govitecan
sibrotuzumab
simtuzumab
sofituzumab vedotin
tacatuzumab tetraxetan
tigatuzumab
trastuzumab
deruxtecan
emtansine
tucotuzumab celmoleukin
vandortuzumab vedotin
vanucizumab
veltuzumab
vorsetuzumab mafodotin
ratmouse hybrid
catumaxomab
ertumaxomab
depatuxizumab mafodotin
duvortuxizumab
ontuxizumab
withdrawn
clinical trials
phase iii
interleukin receptor
modulators
interleukin 1
gevokizumab
aldesleukin
denileukin diftitox
interleukin 3
promegapoietin
interleukin 4
interleukin 13
pitrakinra
dupilumab
benralizumab
clazakizumab
levilimab
interleukin 7
interleukin 9
interleukin 10 csif
interleukin 11 agif
oprelvekin
anrukinzumab
tralokinumab
alt803
interleukin 15
a
e interleukin 25
f
perakizumab
interleukin 18
interleukin 37
il18bp
interleukin 19
interleukin 20
interleukin 24
fletikumab
interleukin 21
interleukin 22
fezakinumab
brazikumab
interleukin 27 interleukin 30
interleukin 28
b ifn3
interleukin29 ifn1
interleukin 31
interleukin 33
interleukin 36
1
1
1
interleukin 38
jak
interleukin 14 taxilin alpha hmwbcgf
interleukin 16
il22r1
interleukin 26
interleukin 32
interleukin 34
mcsfrcsf1r
interleukin 35
efavaleukin alfa
|
Links to external pages
Outloing links
es.wikipedia.org
fr.wikipedia.org
it.wikipedia.org
ru.wikipedia.org
www.wikidata.org
dailymed.nlm.nih.gov
www.whocc.no
commonchemistry.cas.org
www.drugbank.ca
precision.fda.gov
www.kegg.jp
www.ebi.ac.uk
www.tga.gov.au
web.archive.org
web.archive.org
www.accessdata.fda.gov
pubmed.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.doi.org
pubmed.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.clinicaltrials.gov
web.archive.org
pubmed.ncbi.nlm.nih.gov
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.doi.org
pubmed.ncbi.nlm.nih.gov
api.semanticscholar.org
www.ncbi.nlm.nih.gov
www.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
foundation.wikimedia.org
foundation.wikimedia.org
foundation.wikimedia.org
www.wikimediafoundation.org
SEO Advice for en.wikipedia.org
In this section we provide pointers on how you can to optimize your web page so it can be found more easily by search engines and how to make it rank higher by optimizing the content of the page itself. For each of the individual criteria the maximum score is 100%. A score below 70% is considered to be indication that the page is not complying with general SEO standards and should be evaluated and/or fixed. Not every factor is weighted the same and some are not as important as others. Relatively unimportant factors like meta keywords are not included in the overall score.
Item | Factor | Pointers | |
---|---|---|---|
PageTitle | 100% | Far too many sites lack a page title. A page title is the first thing that shows in the search results so always use the title element. | |
Title relevance | 100% | A title should reflect the contents of a site. This site has a 100 % match | |
Title Length | 30% | Limit your title to anywhere between 40 and 70 characters. Your title was 23 characters long | |
Meta Description | 0% | A meta description is the second element that shows in the search results so always use the meta description. | |
Meta description length | 0% | The meta description should be between 145 and 160 characters. This meta description is 1 characters long. | |
Meta description relevance | 0% | Meta Description should reflect the contents of a site. This site has a 0 % match | |
Number of internal links | 30% | Linking to internal pages makes pages easier to find for search engines. Try to keep the number of links on your page roughly below 100. There are 649 internal links on this page. | |
Folder structure | 100% | We found a folder structure in the links on your page. A good folder structure makes a site easier to navigate. We found 3 level 1 folders and 7 folders above or in the first level of navigation. | |
Headings | 35% | Headers should reflect the contents of a site. This site has a 15 % match | |
Links | 10% | Link anchors should to some degree reflect the contents of a site. This site has a 5 % match | |
Image alt tags | 25% | Image alt tags should to some degree reflect the contents of a site. This site has a 9 % match | |
Bold and italic | 39% | Bold and italic tags should reflect the contents of a site to some degree. This site has a 13 % match | |
Html ratio | 30% | Try to keep the html / text ratio as low as possible. More html means longer loading times. Layout should be handled in a serpate css file | |
Image descriptions | 83% | 83.333333333333 % of all images have been described via the "alt" attribute. Describing images with relevant text may lead to better results in the search engines. | |
Page errors | 100% | Pages with no errors display significantly faster on most browsers. We detected 0 errors and warnings | |
WordCount | 20% | An ideal page contains between 400 and 600 words.This page contains 1836 words | |
Server response time | 100% | A fast server speeds up a website. This server responds 94.14% faster then average | |
Gzip compression | 30% | This site does not use Gzip compression. Pages may not display as fast as they could | |
Keywords in Domainname | 100% | There are important keywords in your domain name | |
Keywords in domain path | 100% | There are important keywords in the domain path | |
Structured Data | 100% | Structured data makes it easier for search engines to index your website | |
Inline css | 0% | Do not use inline css declarations. Inline css will slow down the rendering of the website. We detected 202 inline style declarations ( <a style="color:green">) with a size of 3789 bytes | |
Excessive use of the same words | 100% | There is no indication that there are one or more keywords that are used excessively. | |
Frames or iframes | 100% | Perfect, detected not (i)frames on your webpagina | |
Flash | 100% | Perfect, we detected no flash objects on your page | |
Css | 30% | We detected too much (2) CSS files on your page. Css files block the loading of a webpage. | |
Javascript | 100% | Perfect, we did not detect too many blocking JavaScript files | |
Mobile Website | 100% | Perfect, we found a responsive design for mobile users | |
Most important heading | 100% | Perfect, we detected a correct use of the most important (h1) heading! | |
Normalized headings | 40% | We dit not font a normalized heading structure. A heading 2 (h2) for example should be followed by a heading of an equal level (h2), a child heading (h3) or even a aprent heading (h1). |
How would you like to have SEO advice for all your pages ?? Start your SEO Dashboard and optimize your website!
en.wikipedia.org images and descriptions
10 images found at en.wikipedia.org Images can improve the user experience for a website by making a pag visually appealing Images can also add extra keyword relevance to a webpage by using alt tags. Images can also slow down a website. If the width and height for a picture is not specified for a browser know in advance how large the image is. A browser must first load the picture and see before it knows how much space should be on the page. Upon reservation In the meantime, the browser can do little but wait. When the height and width for the plate are given in the HTML code, a browser just continues to build for a page while the images load in the background.
http://en.wikipedia.org/static/images/icons/wikipedia.png height: 50 width: 50 description: no alt description found |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-wordmark-en.svg height: height attribute not set width: width attribute not set description: wikipedia |
|
http://en.wikipedia.org/static/images/mobile/copyright/wikipedia-tagline-en.svg height: 13 width: 117 description: the free encyclopedia |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/x_mark.svg/7px-x_mark.svg.png height: 8 width: 7 description: ☒ |
|
https://upload.wikimedia.org/wikipedia/en/thumb/f/fb/yes_check.svg/7px-yes_check.svg.png height: 7 width: 7 description: check |
|
https://upload.wikimedia.org/wikipedia/en/thumb/6/62/pd-icon.svg/12px-pd-icon.svg.png height: 12 width: 12 description: public domain |
|
https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/who_rod.svg/8px-who_rod.svg.png height: 19 width: 8 description: icon |
|
https://login.wikimedia.org/wiki/special:centralautologin/start?type=1x1 height: 1 width: 1 description: no alt description found |
|
http://en.wikipedia.org/static/images/footer/wikimedia-button.png height: 31 width: 88 description: wikimedia foundation |
|
http://en.wikipedia.org/static/images/footer/poweredby_mediawiki_88x31.png height: 31 width: 88 description: powered by mediawiki |
How are images contributing to your SEO site-wise ? Your leading content tool has the awnsers!